News and Trends 19 Aug 2022
Axsome Therapeutics’ MDD treatment gets green light from FDA
The U.S. Food and Drug Administration (FDA) has approved Axsome Therapeutics, Inc.’s Auvelity tablets for the treatment of major depressive disorder (MDD) in adults. Auvelity (dextromethorphan HBr -bupropion HCl) is…